The Prior Authorization Gauntlet Now, this is where it gets really interesting
On 23 July 2026, Lilly reported positive topline results from two further pivotal trials, both at 80 weeks, and both meeting their primary endpoints
Depending on lab results, hormone markers, and the complete clinical picture, your provider may recommend other peptides that support metabolic health, body composition, recovery, or hormone optimization through hormone replacement therapy (HRT)
Some trials including latestage studies of oral semaglutide did not show a meaningful slowing of memory decline or disease progression compared with placebo
Weight loss may also help lower blood pressure and improve cholesterol levels, which could decrease the risk of heart disease and other cardiovascular problems